1. Objectives of the HFSP Accelerator Grants
The aim of the Human Frontier Science Program is to promote, through international cooperation, basic research focused on the elucidation of the sophisticated and complex mechanisms of living systems, for the benefit of all humankind. It aims to complement, not duplicate, the frontier life science programs of the countries that financially support HFSPO.
HFSPO attaches highest importance to novelty, scientific merit, internationality, and interdisciplinarity. The aim of this new instrument is, to make HFSP supported research more inclusive by integrating scientists working in countries that have been less well represented in HFSP grants, into a working team, and through the team into the larger HFSP community. The new accelerator team members support both the growth of the HFSP research community, becoming more inclusive, equitable and diverse, and the integration of researchers from underrepresented countries while still upholding the rigor of the HFSP review process. Complementarity of the research team, synergy of expertise and activities and added value for the HFSP project will be important aspects in the selection of awardees.
The call for Accelerator Grants 2027 is restricted to HFSP Research Grant teams – Program or Early Career awarded in March 2026. They are invited to apply for an HFSP Accelerator Grant allowing the integration of one additional member into the project. The new member must be working in a research institution in one of the following countries: (India, Japan, New Zealand, Norway, Republic of Korea, Singapore, South Africa). Only scientists working in one of these eligible countries can be invited to join an existing HFSP grant team.
If awarded, the accelerated teams will receive 100 000 USD per year in addition to the awarded Research Grant sum, for the years 2 and 3 of the grant. The team will be asked to decide about the exact distribution of the enlarged award sum keeping in mind that the accelerator team member should have the means to also develop their laboratory and purchase the instrumentation required to do the proposed work.
2. Summary of the application and review process
HFSP developed a new application and review process for this new grant; applications are to be submitted through the HFSP application site Proposal Central by the PI of a newly awarded grant team, on behalf of the entire team (for more details, a PC guide is available here). If other members of the team have established or hold the contact to the new member, they can be given access to edit the application.
The proposal has to contain an abstract and a research plan describing the new sub-project, outlining how this research and the new member will add value to the project. In addition to contributing to the research plan, the accelerator team member needs to provide information (CV and publications, in the same format as regular team members did in the Research Grant proposal) and sign the application together with the PI of the team. A signature from an institutional official of the new member’s institution is also required.
The application deadline is 22 September 2026. Applications will be evaluated by the Research Grant Review Committee, which will discuss and rank them at their regular meeting in January 2027. The HFSPO Board of Trustees will take a funding decision before the end of March 2027, and when awarded, the accelerator team member joins the team starting with year 2 of the original Research Grant period. The team is awarded an additional 100 000 USD per year.
3. The scientific scope of the application: New expertise, new perspectives
The new sub-project should be well defined, clearly connected to the original project but distinctly different from the other sub-projects. The aim is for the new sub-project to add new expertise or bring innovative, cutting-edge technology to the team. Optimally, the Accelerator team member will contribute a completely new dimension to the research topic. Please give sufficient detail on methods and experimental plans as well as the expertise of the new team member for the reviewers to evaluate the sub-project. Feasibility is not an evaluation criterion, but if the new sub-project entails risk, please comment on it and explain a mitigation strategy. Publications listed in the application should allow reviewers to judge the expertise of the new team member, which has relevance to the proposed project.
Distribution of funds among team members
The HFSP Accelerator Grant is awarded to the team and thus, the award sum is added to their annual budget from the second year onwards. While the team will be asked to decide about the distribution of the funds, as in the first year, it is expected that the accelerator team member will be treated equally to the other team members. Somewhat uneven distribution of funds may be acceptable, for instance if one member needs to purchase equipment in one year, if a jointly supervised student is paid by one institution or in similar cases but will have to be approved by the Director of Research Grants.
6. Award conditions, agreement and use of funds
The same award conditions as for the regular Research Grant apply. An agreement will have to be signed by the accelerator team member and their institution. The same general rules as for the Research Grants apply, including for overhead (max 10% of the direct costs). Scientists in for-profit organizations may not receive any funds. Scientists working in institutions with mixed status can receive funds. If the institution has a mixed status and receives both public and private funds, it is necessary that the HFSP project does not overlap with a project sponsored by a private company and that there is a project-by-project accounting.
A budget is not required. The following information is provided to allow new team members to understand which expenditures are permitted in case an award is made.
Equipment
Purchase of larger equipment is possible but must be essential for the proposed project.
Materials and supplies
Costs of reagents, animals, disposables, computer software necessary for the scientific collaboration.
Services
Consulting services and computer services specific to the project, including rental fees (fees for computer or telephone networks may be included in the indirect costs).
Salaries
No salary support (including summer salaries) for the Principal Applicant, Co-Applicant or other faculty, institutional staff such as secretaries or laboratory managers, and no student tuition fees may be paid. Salaries may be provided for research assistants (post-doctoral scientists, graduate students, technicians) essential for the new collaborative project.
Communication expenses
Publication costs (including open access fees), article translations, mail, express courier services.
Travel and per diem
- Travel costs and per diem allowances (up to three months each year), for team members and their personnel visiting other team members.
- Travel costs and per diem allowances for fieldwork or visits to research facilities.
- Scientific meetings or training courses related to the HFSP project.
- Costs for attending the annual awardee meeting organized by the HFSPO.
Indirect costs (overheads)
No more than 10% of the direct costs of the award, at each research institution, may be used for indirect costs.
7. Ethical considerations
Awardees must observe the highest ethical standards in conducting all research supported by the Program. If awarded, all team members have to agree to conform strictly to the national and institutional codes of practice, regulations and laws, which govern the ethical conduct of scientific research in their own institution. Institutions must inform HFSPO if national or institutional codes of practice, regulations, or laws have been infringed in the performance of the award. All awardees must also agree not to undertake any research jointly with scientists in another country where experimental procedures, which are forbidden in their own laboratories/institutions are permissible. Examples of national guidelines can be found via links on Good Scientific Practice or HFSPO’s policy on scientific misconduct available on the HFSP website.
8. Intellectual property rights and publications
HFSPO will not claim any intellectual or commercial property rights that may be generated through the research it sponsors. HFSPO will not become involved in any dispute which may arise about the ownership of such rights. The assignment of any such rights (and any income arising from them) is to be determined by the procedures and regulations which apply in the laboratory/institution in which the research is conducted.
In considering the possible commercial importance of discoveries which arise from research sponsored by the Program, all awardees must agree that submission of manuscripts for publication of these discoveries in scientific journals will not be delayed for more than 45 working days after the manuscript is completed. An acknowledgement of support by the Human Frontier Science Program must be included in all publications resulting from work carried out under the grant.
9. Reports
The accelerator team member, as all Grant team members, has to submit a final financial report at the end of the grant period. Awarded teams will include the project component added through the HFSP Accelerator Grant and the new team member in the annual scientific reports and in the final scientific report, and accelerator team member will be requested to fill specific sections in these reports.
Novelty is arguably the single most important HFSP characteristic.
HFSP seeks projects that challenge existing paradigms and extend the frontiers of life science through novel approaches and techniques. Preliminary results are deliberately not required, because HFSP wants to encourage genuinely new lines of investigation.
A competitive proposal should answer:
What fundamentally new biological idea are we testing?
It should not merely apply an established technology to an established biological question.
Strong
New biological principle + unconventional approach + potentially unexpected discovery
Weak
Existing hypothesis + standard technique + incremental improvement
HFSP explicitly states that obvious next steps and incremental advances are unlikely to succeed.
This is a critical eligibility/fit factor.
HFSP supports fundamental research aimed at understanding the complex mechanisms of living systems. Research may range from genes and molecules through cells, tissues, organs, organisms, cognition, populations, and ecosystems.
A project should therefore focus on:
Critical distinction
A project about cancer, for example, can potentially fit HFSP if the question is:
"What fundamental biological mechanism allows cells to reorganize their state?"
But a project primarily asking:
"Can we develop a better cancer drug?"
would generally be outside HFSP's scope. HFSP specifically excludes primarily clinical/pharmaceutical projects, drug-target identification, and drug development.
HFSP gives very high importance to interdisciplinary research.
The team should ideally combine genuinely different forms of expertise, such as:
HFSP emphasizes that each member should contribute a unique and distinctly different approach to the scientific question.
Simply putting several biologists from neighboring fields together is generally not sufficient.
International collaboration is a formal defining feature of HFSP.
Research Grant teams normally consist of 2–4 scientists based in different countries, preferably with intercontinental representation. Two members from the same institution are generally not eligible, and teams with all members in one country are ineligible.
HFSP wants the international structure to contribute scientifically—not merely satisfy an administrative requirement.
A strong application explains:
HFSP explicitly looks for projects with the potential to move the frontiers of life sciences and lead to a breakthrough.
The proposal should therefore communicate the potential consequence of success.
For example:
Current understanding → new discovery → new biological framework
rather than merely:
Current method → slightly better result
The strongest proposals often have the potential to influence multiple areas of biology, rather than only a very narrow subfield.
This is one of the most important and frequently misunderstood HFSP criteria.
The team should not look like:
Scientist A does project A + Scientist B does project B + Scientist C does project C.
Instead:
A's expertise makes B's experiment possible, B's findings change C's model, and C's analysis feeds back into A's biological experiment.
HFSP reviewers pay particular attention to the planned interactions between team members and whether the collaboration is genuinely integrated.
The proposal should explicitly explain:
HFSP wants researchers to develop new lines of research, rather than simply continue their current work.
The project should be significantly different from the applicants' ongoing research. Team members are normally expected not to have previously collaborated or published original research together.
This creates a distinctive HFSP success pattern:
Established expertise + completely new scientific direction + new collaborator + new methodology
That is much more attractive than:
Existing project + existing collaborators + additional funding.
HFSP intentionally accepts scientific risk because frontier discoveries are inherently uncertain.
Unlike many grant agencies, preliminary results are not required for Research Grant applications. Applicants are expected to address risks and provide mitigation strategies.
The strongest proposal therefore does not pretend the research is guaranteed to work.
Instead:
"This is a risky idea because X. If X fails, we will use Y. Either outcome will answer an important biological question."
That is a much better HFSP approach.
High-risk does not mean poorly designed.
HFSP still evaluates:
The key balance is:
Conceptually risky ≠ technically careless
HFSP places special emphasis on early-career scientists through its Research Grants – Early Career program.
For Early Career Research Grants, all team members must:
Early-career applicants are expected to demonstrate particularly strong interdisciplinarity.
The aim of the HFSP Accelerator Grants is a more equitable spread of the benefits of HFSP grants. Therefore, only scientists working in one of the eligible countries (India, Japan, New Zealand, Norway, Republic of Korea, Singapore, South Africa) can be recruited to a team, in the framework of the HFSP Accelerator Grant. For detailed eligibility criteria for accelerator team members, see the relevant tab in the upper menu.
In short:
For accelerator team members, the same general criteria apply as for the regular team members of Research Grants – Program. They must have an independent group leader position and be able to decide about their own research direction and budget. Post-docs are not eligible. The main criteria of HFSP peer review, including that of HFSP Accelerator Grants, is the scientific quality of the proposed research and its potential to extend scientific frontiers. Current HFSP awardees (award years 2023 onwards) and scientists who are part of a team that applies with the Full Proposal for a 2027 Research Grant are not eligible to apply.
Reviewers are instructed to evaluate whether the new project component is “frontier”, adding significant expertise and complementary approaches to the originally awarded project; whether the new member is adding to the interdisciplinarity and capable to do that project component; whether the new member will be integrated well into the team and thus, benefit from the participation. Feasibility is not a criterion but if the project entails risk, it should be discussed. Based on these criteria, the reviewers will decide whether to recommend the proposal for funding.
Eligible Countries:
Sponsor Institute/Organizations: Human Frontier Science Program Organization
Sponsor Type: Corporate/Non-Profit
Address: 12 quai Saint-Jean 67080 Strasbourg
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Sep 22, 2026
Sep 22, 2026
Varies
varies
Affiliation: Human Frontier Science Program Organization
Address: 12 quai Saint-Jean 67080 Strasbourg
Website URL: https://www.hfsp.org/accelerator-grant
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.